Target intelligence / Profile preview

Dietary triglycerides and other lipids (TG)

Target
TG
Molecular classification
Lipids, Nutrients, Metabolic substrates
01

Overview

Dietary triglycerides and other lipids represent the primary source of exogenous fats in the human diet, serving as critical energy reserves and structural components of cellular membranes (StatPearls: Physiology, Triglycerides, 2023). These molecules are composed mainly of triacylglycerols, which are hydrolyzed by lipases in the gastrointestinal tract into free fatty acids and monoglycerides for absorption (NIH: Lipid Metabolism, 2023). While they are essential for physiological processes, including the transport of fat-soluble vitamins, chronically elevated levels are a major risk factor for cardiovascular disease, obesity, and pancreatitis (American Heart Association: Management of Cholesterol, 2018).\n\nIn pharmacology, dietary lipids are considered substrates rather than protein targets; therapeutic strategies focus on inhibiting the enzymes or transporters responsible for their breakdown and uptake (PubChem: Triglyceride, 2024). For instance, lipase inhibitors like Orlistat prevent the digestion of triglycerides, while other agents like Ezetimibe block the intestinal absorption of cholesterol, effectively lowering systemic lipid levels and mitigating metabolic risk (FDA: Orlistat Label, 2015; StatPearls: Ezetimibe, 2023).

Other names
Dietary fatsTriacylglycerolsNeutral fatsExogenous lipidsDietary cholesterol
02

Mechanism of action

Drugs targeting the processing of dietary lipids typically act by inhibiting gastrointestinal enzymes, such as pancreatic lipase, to prevent the breakdown of triglycerides into absorbable components, or by inhibiting transport proteins like NPC1L1 to block the uptake of cholesterol into enterocytes (StatPearls: Orlistat, 2023; StatPearls: Ezetimibe, 2023).

03

Biological functions

Energy storageStructural component of cell membranesSignaling molecule precursorAbsorption of fat-soluble vitamins
04

Disease associations

HypertriglyceridemiaObesityCardiovascular diseaseAtherosclerosisMetabolic syndromeAcute pancreatitis
05

Safety considerations

Steatorrhea (oily stools)Malabsorption of fat-soluble vitamins (A, D, E, K)Gastrointestinal distressUrgency to defecateFlatulence with discharge
06

Interacting drugs

Orlistat

4 more in the full profile.

07

Biomarkers

Serum triglyceride levelsLow-density lipoprotein cholesterol (LDL-C)High-density lipoprotein cholesterol (HDL-C)Total cholesterolApolipoprotein B

Beyond the preview

Go deeper on Dietary triglycerides and other lipids (TG).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Dietary triglycerides and other lipids (TG).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call